884048-45-7 Usage
General Description
"(3S,4R)-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid" is a chemical compound with a complex molecular structure. It is a derivative of pyrrolidine-3-carboxylic acid, with a tert-butoxycarbonyl group attached to the first carbon and a phenyl group attached to the fourth carbon. The compound is chiral, with a stereochemistry of 3S,4R. (3S,4R)-1-(tert-butoxycarbonyl)-4-phenylpyrrolidine-3-carboxylic acid is commonly used in organic chemistry and pharmaceutical research, as it can serve as a building block for various drug molecules and other biologically active compounds. The tert-butoxycarbonyl group serves as a protecting group for the carboxylic acid, allowing for selective chemical reactions to be carried out.
Check Digit Verification of cas no
The CAS Registry Mumber 884048-45-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,4,0,4 and 8 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 884048-45:
(8*8)+(7*8)+(6*4)+(5*0)+(4*4)+(3*8)+(2*4)+(1*5)=197
197 % 10 = 7
So 884048-45-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H21NO4/c1-16(2,3)21-15(20)17-9-12(13(10-17)14(18)19)11-7-5-4-6-8-11/h4-8,12-13H,9-10H2,1-3H3,(H,18,19)
884048-45-7Relevant articles and documents
HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
-
, (2021/09/04)
The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.
Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids
-
Page/Page column 22; 23, (2008/06/13)
The present invention relates to a process for the preparation of cis substituted cyclic β-aryl or heteroaryl carboxylic acid derivatives in high diastereo- and enantioselectivity by enantioselective hydrogenation in accordance with the following scheme w
